[ad_1]
Synopsis
It’s a seemingly easy, affordable, and low-risk treatment being suggested for Covid-19 patients. In reality, plasma therapy remains an experimental intervention and has failed to scale up as a standard treatment. Anecdotal results have helped fuel hype about the therapy, highlighting the need for hard evidence backed by standard safety procedures.
For two momentous events separated by a century, the similarities are uncanny. The Spanish flu of 1918 and the current Covid-19 outbreak spanned continents, overwhelmed healthcare systems, and raged on for several months. Responses to both the crises were marked by confusion and misinformation. But amid all the chaos, one simple therapy offered some hope. Like they did a hundred years ago, doctors and policymakers are falling back on
BY
- FONT SIZE
AbcSmall
AbcMedium
AbcLarge
Sign in to read the full article
You’ve got this Prime Story as a Free Gift
Yearly
(Save 49%)
₹2499
15
Days Trial
+Includes DocuBay and TimesPrime Membership worth ₹1499 & ₹999 resp.
2-Year
(Save 63%)
₹3599
15
Days Trial
+Includes DocuBay and TimesPrime Membership worth ₹1499 & ₹999 resp.
Already a Member? Sign In now
Why ?
Sharp Insight-rich, Indepth stories across 20+ sectors
-
Access the exclusive Economic Times stories, Editorial and Expert opinion
-
Clean experience with
Minimal Ads -
Comment & Engage with ET Prime community -
Exclusive invites to Virtual Events with Industry Leaders -
A trusted team of Journalists & Analysts who can best filter signal from noise
[ad_2]
Source link
